PANTHERx Rare Celebrates Fifth Patient Choice Award Win
Read the Official PANTHERx Press Release. For a fifth time, PANTHERx Rare has been recognized as the winner of the annual, Specialty Pharmacy Patient Choice Award™. Since 2016, the Managed …
Blog
Blog
New Article from PANTHERx Examines the Evolution of Specialty Pharmacy Channel Strategy
Change has been a constant in the specialty pharmacy industry since its inception over two decades ago. New medications are routinely launched, more patient populations receive treatment, and public awareness …
Celebrating Rare Disease Day, Today & Every Day
The History of Rare Disease Day On February 29th, 2008, EURORDIS, a non-profit patient alliance of now nearly one thousand organizations from 73 countries, celebrated the first Rare Disease Day …
PANTHERx® Rare Selected by Aadi Bioscience to Distribute FYARRO™ (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for advanced malignant perivascular epithelioid cell neoplasm (PEComa)
Read the Official PANTHERx Press Release. PANTHERx Rare announces that it has been selected by Aadi Bioscience as the exclusive U.S. pharmacy distribution partner for new drug FYARRO™ (sirolimus protein-bound …
PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome
Read the Official PANTHERx Press Release. PANTHERx Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive …
Q3 2021: PANTHERx Continues to Hold #1 Ranking in Quarterly MMIT Patient Satisfaction Survey
This past year has proven to be one of record patient satisfaction scores for PANTHERx Rare. In the first half of 2021, PANTHERx led the independent specialty pharmacy category of …
2021 Marks Milestone Fourth Patient Choice Award for PANTHERx Rare
Read the Official PANTHERx Press Release. PANTHERx Rare has again been recognized as the winner of the annual, national Specialty Pharmacy Patient Choice Award™. “The results of the Managed Markets …
PANTHERx® Rare Pharmacy Selected by ChemoCentryx to Distribute TAVNEOS™ (avacopan) in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Read the Official PANTHERx Press Release. PANTHERx Rare Pharmacy announces that it has been selected by ChemoCentryx as a limited distribution partner for new drug TAVNEOS (avacopan). TAVNEOS, an orally …
Outstanding Patient Satisfaction Scores Merit PANTHERx #1 Rank for Q2 2021
PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the second quarter …
PANTHERx Rare Earns Rare Disease Pharmacy Designation from URAC
PANTHERx Rare is excited to announce that it has earned URAC’s Rare Disease Center of Excellence Designation. This distinction, given only to pharmacies that establish the high level of skill …